{
  "ticker": "JNJ",
  "target_date": "2025-02-03",
  "actual_date": "2025-02-03",
  "collected_at": "2025-12-08T11:21:15.152232",
  "price": {
    "open": 147.49,
    "high": 147.94,
    "low": 146.3,
    "close": 147.3592071533203,
    "volume": 6687500,
    "change_1d_pct": -0.18,
    "change_7d_pct": 3.57,
    "change_30d_pct": 3.73
  },
  "technicals": {
    "rsi_14": 67.08,
    "sma_20": 142.91,
    "sma_50": 143.77,
    "macd": 1.339,
    "macd_signal": 0.513,
    "macd_histogram": 0.826,
    "bb_upper": 149.71,
    "bb_lower": 136.1,
    "price_vs_sma20_pct": 3.12,
    "price_vs_sma50_pct": 2.5,
    "volume_ratio": 0.69
  },
  "fundamentals": {
    "market_cap": 488821882880,
    "pe_ratio": 19.583977,
    "forward_pe": 19.140566,
    "price_to_book": 6.1580725,
    "price_to_sales": 5.3046904,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.37,
    "pct_from_52w_low": 44.22
  },
  "macro": {
    "spy": {
      "price": 592.58,
      "change_1d_pct": -0.67,
      "change_7d_pct": -1.68
    },
    "vix": {
      "level": 18.62,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.54
    },
    "dollar_index": {
      "level": 108.99
    },
    "gold": {
      "price": 2833.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "You Deserve Reliable Income: 2 Undervalued Dividends For Long-Term Growth",
      "source": "SeekingAlpha",
      "datetime": 1738572660,
      "summary": "UPS and JNJ present strong dividends and attractive valuations. See why these durable companies are great for a buy-and-hold strategy with long-term growth.",
      "url": "https://finnhub.io/api/news?id=24078a95fb45b8c57eb9e573b89cc4fe1a41bc2a9c63ba693eb4cd9f4fbed470"
    },
    {
      "headline": "J&J: CHMP gives the green light for subcutaneous Rybrevant",
      "source": "Finnhub",
      "datetime": 1738569317,
      "summary": "Janssen-Cilag International NV announces that the Committee for Medicinal Products for Human Use of the EMA has recommended the extension of the marketing authorization for the subcutaneous...",
      "url": "https://finnhub.io/api/news?id=aa928d2ac8920896e9061fb7158a24d22aeebbb54832061fae0dba49a8bd27f2"
    },
    {
      "headline": "Johnson & Johnson : CHMP recommends subcutaneous RYBREVANT\u00ae\u25bc (amivantamab) for the treatment of patients with advanced EGFR mutated non small cell lung cancer",
      "source": "Finnhub",
      "datetime": 1738559298,
      "summary": "Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended an extension of...",
      "url": "https://finnhub.io/api/news?id=6f4843e6b55b2d8da9604e118bbe4d9f43ba6b73596a2177b7e3d17facc3de79"
    },
    {
      "headline": "ORIC Pharmaceuticals: Too Early To Commit, Despite Some Good Early Data",
      "source": "SeekingAlpha",
      "datetime": 1738472729,
      "summary": "ORIC's ORIC-533 was promising but failed in trials, leaving ORIC-114 and ORIC-944 as key pipeline assets. Read why I am neutral on ORIC stock.",
      "url": "https://finnhub.io/api/news?id=b8adc832885d57ebc67b473c3828e685bd6413a80d2eedee4116d146c10d33b7"
    },
    {
      "headline": "What Moved Markets This Week",
      "source": "SeekingAlpha",
      "datetime": 1738391928,
      "summary": "U.S. stocks end a tough week as DeepSeek rattles tech stocks and the Fed Holds interest rates steady. Read more about this week's major events on Wall Street.",
      "url": "https://finnhub.io/api/news?id=d4c5af02929f10b7ead3e6e81da69934cd05a6efeb931ba87d28f5c1e6bafd2a"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-01-22",
      "description": "jnj-20250122.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000003/jnj-20250122.htm"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}